Correction to: miR-125 in Breast Cancer Etiopathogenesis: An Emerging Role as a Biomarker in Differential Diagnosis, Regenerative Medicine, and the Challenges of Personalized Medicine (Non-Coding RNA, (2024), 10, 2, (16), 10.3390/ncrna10020016)

There was an error in the original publication [1]. Reference number 164: “Yang, Y.; Chen, Y.; Liu, J.; Zhang, B.; Yang, L.; Xue, J.; Zhang, Z.; Qin, L.; Bian, R. MiR-125b-5p/STAT3 Axis Regulates Drug Resistance in Osteosarcoma Cells by Acting on ABC Transporters. Stem Cells Int. 2023, 2023, 9997676. https://doi.org/10.1155/2023/9997676.” was retracted prior to the publication of this article. The authors were unaware of the retraction at the time of submission to ncRNA and have confirmed that reference number 164 is not essential to their paper.